CD22 COUNT / EDTA BLOOD

image not found

NABL Cap Accredited 
The CD22 Count test measures CD22-positive B lymphocytes in EDTA blood, offering insight into B-cell development and function. It is useful in evaluating B-cell disorders, immunodeficiency, and certain hematological malignancies. Metropolis Healthcare uses advanced flow cytometry to ensure precise and reliable CD22 count results. These results support clinicians in diagnosis, monitoring, and comprehensive immune assessment.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 2,390.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: C0065

Frequently Asked Questions (FAQ's):

What does this test include?
This test measures CD22-positive B-cell counts in EDTA blood, performed with accuracy by Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses flow cytometry to identify and quantify CD22 expression on B lymphocytes.

Who should take this test?
Patients with suspected B-cell disorders, immune dysfunction, or abnormal blood findings can benefit at Metropolis Healthcare.

Why is CD22 testing important?
Metropolis Healthcare uses this test to assess B-cell maturation and detect abnormal immune patterns.

Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs an EDTA blood sample.

What do low CD22 counts indicate?
Low counts at Metropolis Healthcare may suggest impaired humoral immunity or B-cell depletion.

What do high CD22 counts mean?
High levels at Metropolis Healthcare can occur in reactive or proliferative B-cell conditions.

How long does it take to get results?
Metropolis Healthcare provides timely and reliable results to support effective clinical management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab